Australia 1,4 Butanediol Market Size & Outlook, 2025-2030
Australia 1,4 Butanediol Market, 2018-2030 (US$M)
Australia 1,4 butanediol market highlights
- The Australia 1,4 butanediol market generated a revenue of USD 149.3 million in 2024 and is expected to reach USD 245.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 7.3% from 2025 to 2030.
- In terms of segment, tetrahydrofuran (thf) was the largest revenue generating application in 2024.
- Tetrahydrofuran (THF) is the most lucrative application segment registering the fastest growth during the forecast period.
1,4 butanediol market data book summary
| Market revenue in 2024 | USD 149.3 million |
| Market revenue in 2030 | USD 245.6 million |
| Growth rate | 7.3% (CAGR from 2024 to 2030) |
| Largest segment | Tetrahydrofuran (thf) |
| Fastest growing segment | Tetrahydrofuran (THF) |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tetrahydrofuran (THF), Polybutylene Terephthalate (PBT), Gamma-Butyrolactone (GBL), Polyurethane (PU) |
| Key market players worldwide | Basf SE, Ashland Inc, DCC PLC, Mitsubishi Chemical Group Corp, Evonik Industries AG, LyondellBasell Industries NV Class A, China Petroleum & Chemical Corp Class H, Sipchem, Genomatica |
Other key industry trends
- In terms of revenue, Australia accounted for 1.9% of the global 1,4 butanediol market in 2024.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China 1,4 butanediol market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 7,345.7 million by 2030.
There is a high demand for a wide range of medical equipment in Australia. The market is very competitive and mature. The country's population expects superior-quality medical treatments, and there is a constant need for state-of-the-art medical products.
The country is highly cost-competitive compared to the U.S. for early-phase clinical trials. It is 28.0% cheaper than the U.S. before tax incentives and 60.0% after tax incentives.
No credit card required*
Publish Date: Dec 02, 2024
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
1,4 Butanediol Market Scope
1,4 Butanediol Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Basf SE | View profile | 111,855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | www.basf.com |
| Evonik Industries AG | View profile | 33,409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | www.evonik.com |
| LyondellBasell Industries NV Class A | View profile | 20,000 | One Vine Street, 4th Floor, London, United Kingdom, W1J0AH | www.lyondellbasell.com |
| Ashland Inc | View profile | 3,800 | 8145 Blazer Drive, Wilmington, DE, United States, 19808 | www.ashland.com |
| Mitsubishi Chemical Group Corp | View profile | 74,632 | 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8251 | www.mcgc.com |
| DCC PLC | View profile | 16,600 | Leopardstown Road, DCC House, Foxrock, Dublin, Ireland, D18 PK00 | www.dcc.ie |
| China Petroleum & Chemical Corp Class H | View profile | 368,450 | No. 22 Chaoyangmen North Street, Chaoyang District, Beijing, China, People's Republic of, 100728 | www.sinopec.com |
| Genomatica | View profile | 101-250 | San Diego, California, United States, North America | www.genomatica.com |
| Sipchem | View profile | 5001-10000 | Al Khobar, Ash Sharqiyah, Saudi Arabia, Asia | www.sipchem.com |
Australia 1,4 Butanediol Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 1,4 Butanediol Market Outlook will help companies and investors design strategic landscapes.
Tetrahydrofuran (Thf) was the largest segment with a revenue share of 50.37% in 2024.
Horizon Databook has segmented the Australia 1,4 butanediol market based on tetrahydrofuran (thf), polybutylene terephthalate (pbt), gamma-butyrolactone (gbl), polyurethane (pu) covering the revenue growth of each sub-segment from 2018 to 2030.
There is a high demand for a wide range of medical equipment in Australia. The market is very competitive and mature. The country's population expects superior-quality medical treatments, and there is a constant need for state-of-the-art medical products.
The country is highly cost-competitive compared to the U.S. for early-phase clinical trials. It is 28.0% cheaper than the U.S. before tax incentives and 60.0% after tax incentives.
- Australia 1,4 Butanediol Market Application Outlook (Revenue, USD Million , 2018-2030)
- Tetrahydrofuran (THF)
- Polybutylene Terephthalate (PBT)
- Gamma-Butyrolactone (GBL)
- Polyurethane (PU)
- Others
Reasons to subscribe to 1,4 Butanediol Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of 1,4 Butanediol Market Outlook databook
- Our clientele includes a mix of 1,4 Butanediol Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia 1,4 Butanediol Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia 1,4 Butanediol Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia 1,4 Butanediol Market, 2018-2030 (US$M)
Australia 1,4 butanediol market statistics, by application, 2018-2030 (US$M)
